About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF News
NFO Updates
MF Tools
Return Calculator
SIP Calculator
Home
>
MUTUAL FUND
>
MUTUAL FUNDS
>
SCHEME PROFILE
SCHEME
PROFILE
AMC :
All
360 ONE Mutual Fund
Abakkus Mutual Fund
Aditya Birla Sun Life Mutual Fund
Angel One Mutual Fund
Arudha SIF
Axis Mutual Fund
Bajaj Finserv Mutual Fund
Bandhan Mutual Fund
Bank of India Mutual Fund
Baroda BNP Paribas Mutual Fund
Canara Robeco Mutual Fund
Capitalmind Mutual Fund
Choice Mutual Fund
Diviniti SIF
DSP Mutual Fund
Edelweiss - Altiva SIF
Edelweiss Mutual Fund
Franklin Templeton Mutual Fund
Groww Mutual Fund
HDFC Mutual Fund
Helios Mutual Fund
HSBC Mutual Fund
ICICI Prudential Mutual Fund
IL&FS Mutual Fund (IDF)
Invesco Mutual Fund
iSIF
ITI Mutual Fund
Jio BlackRock Mutual Fund
JM Financial Mutual Fund
Kotak Mahindra Mutual Fund
LIC Mutual Fund
Mahindra Manulife Mutual Fund
Mirae Asset Mutual Fund
Motilal Oswal Mutual Fund
Navi Mutual Fund
Nippon India Mutual Fund
NJ Mutual Fund
Old Bridge Mutual Fund
PGIM India Mutual Fund
PPFAS Mutual Fund
Quant Mutual Fund
Quant SIF
Quantum Mutual Fund
Samco Mutual Fund
SBI - Magnum SIF
SBI Mutual Fund
Shriram Mutual Fund
Sundaram Mutual Fund
Tata Mutual Fund
Taurus Mutual Fund
The Wealth Company Mutual Fund
Titanium SIF
Trust Mutual Fund
Unifi Mutual Fund
Union Mutual Fund
UTI Mutual Fund
WhiteOak Capital Mutual Fund
Zerodha Mutual Fund
Category :
All
Debt - Banking and PSU Fund
Debt - Corporate Bond Fund
Debt - Credit Risk Fund
Debt - Dynamic Bond
Debt - Floater Fund
Debt - Gilt Fund
Debt - Gilt Fund with 10 year constant duration
Debt - Index Fund
Debt - Infrastructure
Debt - Liquid Fund
Debt - Long Duration Fund
Debt - Low Duration Fund
Debt - Medium Duration Fund
Debt - Medium to Long Duration Fund
Debt - Money Market Fund
Debt - Overnight Fund
Debt - Short Duration Fund
Debt - Ultra Short Duration Fund
Debt -Interval Funds - Quarterly
Debt -Interval Funds - Yearly
Equity - Contra Fund
Equity - Dividend Yield Fund
Equity - ELSS
Equity - Flexi Cap Fund
Equity - Focused Fund
Equity - Large & Mid Cap Fund
Equity - Large Cap Fund
Equity - Mid Cap Fund
Equity - Multi Cap Fund
Equity - Sectoral Fund - Auto
Equity - Sectoral Fund - Banks & Financial Services
Equity - Sectoral Fund - Consumption
Equity - Sectoral Fund - Energy & Power
Equity - Sectoral Fund - Infrastructure
Equity - Sectoral Fund - Pharma & Health Care
Equity - Sectoral Fund - Service Industry
Equity - Sectoral Fund - Technology
Equity - Small cap Fund
Equity - Thematic Fund - Global
Equity - Thematic Fund - MNC
Equity - Thematic Fund - Other
Equity - Value Fund
ETFs - Debt
ETFs - Gold
ETFs - Index
ETFs - Other
ETFs - Silver
Fixed Maturity Plans
FoFs (Domestic / Overseas ) - Gold
FoFs (Domestic) - Debt Oriented
FoFs (Domestic) - Equity Oriented
FoFs (Domestic) - Hybrid
FoFs (Domestic) - Silver
FoFs (Overseas)
Hybrid - Aggressive Hybrid Fund
Hybrid - Arbitrage Fund
Hybrid - Balanced Advantage
Hybrid - Balanced Hybrid Fund
Hybrid - Conservative Hybrid Fund
Hybrid - Dynamic Asset Allocation
Hybrid - Equity Savings
Hybrid - Multi Asset Allocation
Index Funds - Nifty
Index Funds - Nifty Next 50
Index Funds - Other
Index Funds - Sensex
Solution Oriented - Children's Fund
Solution Oriented - Retirement Fund - Debt
Solution Oriented - Retirement Fund - Equity
Scheme :
Select Scheme
ICICI Pru Nifty Pharma Index Fund-Reg(G)
Type
Investment In
% of NAV
No. of shares
Value (Rs cr)
Domestic Equities
Sun Pharmaceutical Industries Ltd.
22.0527
121008
20.8097
Domestic Equities
Cipla Ltd.
10.2979
64298
9.7174
Domestic Equities
Divi's Laboratories Ltd.
9.8370
14521
9.2825
Domestic Equities
Dr. Reddy's Laboratories Ltd.
9.3829
69640
8.8540
Domestic Equities
Lupin Ltd.
6.1930
27703
5.8439
Domestic Equities
Laurus Labs Ltd.
5.2135
44401
4.9196
Domestic Equities
Torrent Pharmaceuticals Ltd.
4.8768
11953
4.6019
Domestic Equities
Aurobindo Pharma Ltd.
4.0072
31964
3.7813
Domestic Equities
Alkem Laboratories Ltd.
3.9022
6687
3.6822
Domestic Equities
Glenmark Pharmaceuticals Ltd.
3.7118
17210
3.5026
Domestic Equities
Mankind Pharma Ltd.
3.0088
12926
2.8392
Domestic Equities
Biocon Ltd.
2.8641
68613
2.7027
Domestic Equities
Zydus Lifesciences Ltd.
2.7709
28596
2.6147
Domestic Equities
IPCA Laboratories Ltd.
2.3884
15884
2.2538
Domestic Equities
Abbott India Ltd.
1.8363
597
1.7328
Domestic Equities
J.B.Chemicals & Pharmaceuticals Ltd.
1.8021
9345
1.7005
Domestic Equities
Gland Pharma Ltd.
1.6595
9094
1.5660
Domestic Equities
Wockhardt Ltd.
1.4467
9440
1.3652
Domestic Equities
Ajanta Pharma Ltd.
1.4125
4814
1.3329
Domestic Equities
Piramal Pharma Ltd.
1.2904
70711
1.2177
Total
99.9548
94.3206
Cash & Cash Equivalents and Net Assets
TREPS
0.4698
0.4433
Cash & Cash Equivalents and Net Assets
Net Current Assets
-0.4245
-0.4006
Total
0.0452
0.0427
Back
Top
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
